根治性前列腺切除术对尿液细胞外囊泡中 miRNA 动态的影响。

IF 2.4 3区 医学 Q3 ONCOLOGY
E.V. Shutko B.Sc. , O.E. Bryzgunova Ph.D. , E.A Murina M.Sc. , I.A. Ostaltcev M.B.B.S. , S.E. Krasilnikov M.D. , P.P. Laktionov Ph.D. , M.Y. Konoshenko Ph.D.
{"title":"根治性前列腺切除术对尿液细胞外囊泡中 miRNA 动态的影响。","authors":"E.V. Shutko B.Sc. ,&nbsp;O.E. Bryzgunova Ph.D. ,&nbsp;E.A Murina M.Sc. ,&nbsp;I.A. Ostaltcev M.B.B.S. ,&nbsp;S.E. Krasilnikov M.D. ,&nbsp;P.P. Laktionov Ph.D. ,&nbsp;M.Y. Konoshenko Ph.D.","doi":"10.1016/j.urolonc.2024.06.017","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>Cancer statistics demonstrate leading growth of prostate cancer. As a rule, radical prostatectomy (RP) is a mandatory option in the treatment of localized prostate cancer (PCa). Over 30% of patients develop biochemical resistance after the surgery and over 30% of these patients experience prostate cancer recurrence and metastasis. Currently used PCa patient's diagnostic features fail to identify PCa recurrence. To identify the risk group of PCa patients after RP we attempt to apply miRNAs which were shown as promising liquid biopsy markers for PCa diagnosis and prognosis.</p></div><div><h3>Materials and methods</h3><p>Expression of 14 miRNAs closely involved in the development of prostate cancer from urine extracellular vesicles (uEV) of PCa patients before as well as 3, 6 and 12 months after radical prostatectomy was assessed using RT PCR and compared with their expression from uEV of healthy donors in the current study.</p></div><div><h3>Results</h3><p>It was shown that 22 miRNA pairs prognostic ratios (MPPRs) significantly changed after radical prostatectomy. MPPRs the most promising in terms of evaluating the effectiveness of radical prostatectomy have been identified. These include two groups: MPPRs significantly changed after surgery towards that in healthy donors; and MPPRs, which divided PCa patients into two significantly different subgroups 3 or 6 months after radical prostatectomy.</p></div><div><h3>Conclusions</h3><p>The obtained data indicate that urine EVs represent a valuable source of both MPDR and MPPR for prostate cancer.</p></div>","PeriodicalId":23408,"journal":{"name":"Urologic Oncology-seminars and Original Investigations","volume":"42 11","pages":"Pages 371.e19-371.e30"},"PeriodicalIF":2.4000,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Influence of radical prostatectomy on miRNA dynamics in urine extracellular vesicles\",\"authors\":\"E.V. Shutko B.Sc. ,&nbsp;O.E. Bryzgunova Ph.D. ,&nbsp;E.A Murina M.Sc. ,&nbsp;I.A. Ostaltcev M.B.B.S. ,&nbsp;S.E. Krasilnikov M.D. ,&nbsp;P.P. Laktionov Ph.D. ,&nbsp;M.Y. Konoshenko Ph.D.\",\"doi\":\"10.1016/j.urolonc.2024.06.017\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Purpose</h3><p>Cancer statistics demonstrate leading growth of prostate cancer. As a rule, radical prostatectomy (RP) is a mandatory option in the treatment of localized prostate cancer (PCa). Over 30% of patients develop biochemical resistance after the surgery and over 30% of these patients experience prostate cancer recurrence and metastasis. Currently used PCa patient's diagnostic features fail to identify PCa recurrence. To identify the risk group of PCa patients after RP we attempt to apply miRNAs which were shown as promising liquid biopsy markers for PCa diagnosis and prognosis.</p></div><div><h3>Materials and methods</h3><p>Expression of 14 miRNAs closely involved in the development of prostate cancer from urine extracellular vesicles (uEV) of PCa patients before as well as 3, 6 and 12 months after radical prostatectomy was assessed using RT PCR and compared with their expression from uEV of healthy donors in the current study.</p></div><div><h3>Results</h3><p>It was shown that 22 miRNA pairs prognostic ratios (MPPRs) significantly changed after radical prostatectomy. MPPRs the most promising in terms of evaluating the effectiveness of radical prostatectomy have been identified. These include two groups: MPPRs significantly changed after surgery towards that in healthy donors; and MPPRs, which divided PCa patients into two significantly different subgroups 3 or 6 months after radical prostatectomy.</p></div><div><h3>Conclusions</h3><p>The obtained data indicate that urine EVs represent a valuable source of both MPDR and MPPR for prostate cancer.</p></div>\",\"PeriodicalId\":23408,\"journal\":{\"name\":\"Urologic Oncology-seminars and Original Investigations\",\"volume\":\"42 11\",\"pages\":\"Pages 371.e19-371.e30\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-08-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Urologic Oncology-seminars and Original Investigations\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1078143924005301\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologic Oncology-seminars and Original Investigations","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1078143924005301","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:癌症统计数据表明,前列腺癌的增长速度居高不下。通常,根治性前列腺切除术(RP)是治疗局部前列腺癌(PCa)的必选方案。超过 30% 的患者在手术后会出现生化耐药性,其中超过 30% 的患者会出现前列腺癌复发和转移。目前使用的 PCa 患者诊断特征无法识别 PCa 复发。为了确定RP术后PCa患者的风险群体,我们尝试应用miRNAs,这些miRNAs被证明是有希望用于PCa诊断和预后的液体活检标记物:使用 RT PCR 评估了 PCa 患者根治性前列腺切除术前以及术后 3、6 和 12 个月的尿液细胞外囊泡 (uEV)中与前列腺癌发展密切相关的 14 个 miRNA 的表达,并将其与本研究中健康供体尿液细胞外囊泡中 miRNA 的表达进行了比较:结果表明,根治性前列腺切除术后,22 个 miRNA 对预后比值(MPPRs)发生了显著变化。在评估前列腺癌根治术的有效性方面,最有希望的 MPPRs 已被确定。其中包括两组:术后与健康供体相比有明显变化的MPPRs;以及在前列腺癌根治术后3个月或6个月将PCa患者分为两个明显不同亚组的MPPRs:获得的数据表明,尿液 EVs 是前列腺癌 MPDR 和 MPPR 的重要来源。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Influence of radical prostatectomy on miRNA dynamics in urine extracellular vesicles

Influence of radical prostatectomy on miRNA dynamics in urine extracellular vesicles

Purpose

Cancer statistics demonstrate leading growth of prostate cancer. As a rule, radical prostatectomy (RP) is a mandatory option in the treatment of localized prostate cancer (PCa). Over 30% of patients develop biochemical resistance after the surgery and over 30% of these patients experience prostate cancer recurrence and metastasis. Currently used PCa patient's diagnostic features fail to identify PCa recurrence. To identify the risk group of PCa patients after RP we attempt to apply miRNAs which were shown as promising liquid biopsy markers for PCa diagnosis and prognosis.

Materials and methods

Expression of 14 miRNAs closely involved in the development of prostate cancer from urine extracellular vesicles (uEV) of PCa patients before as well as 3, 6 and 12 months after radical prostatectomy was assessed using RT PCR and compared with their expression from uEV of healthy donors in the current study.

Results

It was shown that 22 miRNA pairs prognostic ratios (MPPRs) significantly changed after radical prostatectomy. MPPRs the most promising in terms of evaluating the effectiveness of radical prostatectomy have been identified. These include two groups: MPPRs significantly changed after surgery towards that in healthy donors; and MPPRs, which divided PCa patients into two significantly different subgroups 3 or 6 months after radical prostatectomy.

Conclusions

The obtained data indicate that urine EVs represent a valuable source of both MPDR and MPPR for prostate cancer.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.80
自引率
3.70%
发文量
297
审稿时长
7.6 weeks
期刊介绍: Urologic Oncology: Seminars and Original Investigations is the official journal of the Society of Urologic Oncology. The journal publishes practical, timely, and relevant clinical and basic science research articles which address any aspect of urologic oncology. Each issue comprises original research, news and topics, survey articles providing short commentaries on other important articles in the urologic oncology literature, and reviews including an in-depth Seminar examining a specific clinical dilemma. The journal periodically publishes supplement issues devoted to areas of current interest to the urologic oncology community. Articles published are of interest to researchers and the clinicians involved in the practice of urologic oncology including urologists, oncologists, and radiologists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信